Veracyte stockholders approve 2.5 million share increase to equity incentive plan
At its June 17, 2025 annual meeting, Veracyte stockholders approved an amendment adding 2,500,000 shares to the 2023 Equity Incentive Plan and elected all seven director nominees. Stockholders also ratified Ernst & Young LLP as auditor for 2025 and approved future say-on-pay votes every year. The plan amendment passed with 50,604,131 votes for and 19,070,837 against, so the larger share reserve adds potential dilution for existing holders.
Key points
- Plan amendment adds 2,500,000 shares of common stock to the 2023 Equity Incentive Plan; approved 50,604,131 for, 19,070,837 against, 15,258 abstain
- All seven director nominees elected to serve until the 2026 annual meeting
- Ernst & Young LLP ratified as independent registered public accounting firm for fiscal year ending December 31, 2025
- Stockholders approved holding non-binding say-on-pay votes every year; next frequency vote expected at the 2031 annual meeting
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:54 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 18, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.